Search for: "Bristol-Myers Squibb U.S. Pharmaceutical Group"
Results 21 - 40
of 43
Sorted by Relevance
|
Sort by Date
9 Jul 2015, 3:28 pm
Xarelto, has grabbed a 32 percent market share in the highly competitive anticoagulant market, significantly ahead of Boehringer’s Pradaxa and Bristol-Myers Squibb’s Eliquis, the other two new anticoagulants in the market. [read post]
28 May 2008, 8:56 am
"There's not been a default but there's a complete loss of liquidity.'' In January, Bristol-Myers Squibb booked unrealized pretax losses of $142 million on $811 million of ARS, (It also replaced its treasurer.) [read post]
20 Mar 2009, 2:05 am
Levine, 2009 WL 529172 (U.S. [read post]
24 Mar 2015, 11:54 am
Xarelto, has grabbed a 32 percent market share in the highly competitive anticoagulant market, significantly ahead of Boehringer’s Pradaxa and Bristol-Myers Squibb’s Eliquis, the other two new anticoagulants in the market. [read post]
11 Jan 2006, 8:21 am
The U.S. biotech firms have been brought together under the recently formed American BioIndustry Alliance, which includes pharmaceutical companies Merck, Pfizer, Bristol Myers-Squibb and Eli Lilly, as well as General Electric and Procter & Gamble. [read post]
25 Jan 2023, 1:37 pm
The settlement listed in the hundred spot on the list is 2006 settlement of $185 million in the Bristol-Myers Squibb Co. case. [read post]
13 Aug 2010, 12:46 pm
See Bristol-Myers Squibb Co. v. [read post]
1 Oct 2007, 1:08 am
Bristol-Myers Squibb to Pay $515M to Settle Probes of Drug Marketing
The Associated Press
Bristol-Myers Squibb Co. and a former subsidiary have agreed to pay more than $515 million to settle federal and state investigations into their drug marketing and pricing practices. [read post]
6 Jan 2023, 2:33 pm
Bristol-Myers Squibb paying $75 million to resolve allegations was the seventh largest Healthcare Fraud recovery on last year’s list. [read post]
19 Jun 2017, 12:47 pm
Before we can even finish pondering that, Alito is on to his second case, Bristol-Myers Squibb Co. v. [read post]
9 Nov 2009, 6:01 am
Department of Justice finds that they deceptively marketed drugs for unapproved uses, putting millions of people at risk of chest infections, heart attacks, suicidal impulses or death. $7 Billion in Penalties Since May 2004, Pfizer, Eli Lilly & Co., Bristol-Myers Squibb Co. and four other drug companies have paid a total of $7 billion in fines and penalties. [read post]
10 Sep 2012, 7:28 pm
Mich. 1996); Bristol-Myers Squibb Co. v. [read post]
22 Jun 2011, 7:09 am
Senators, Members of U.S. [read post]
14 Sep 2011, 12:07 pm
Senators, Members of U.S. [read post]
14 Sep 2011, 12:07 pm
Senators, Members of U.S. [read post]
14 Sep 2011, 12:08 pm
Senators, Members of U.S. [read post]
25 Apr 2015, 11:03 am
In the course of identifying this second assumption, the Manual now points out that the doubling argument turns on applying “an average risk for the group” to each individual in the group. [read post]
2 Mar 2012, 6:52 am
Bristol-Myers Squibb (?) [read post]
9 Aug 2012, 5:00 am
Bristol-Myers Squibb (?) [read post]
6 May 2016, 12:30 pm
Tap Pharmaceuticals, Inc., 2004 WL 2550593, at *5 (W.D. [read post]
